Crédit Industriel et Commercial’s Inozyme Pharma INZY Stock Holding History

Crédit Industriel et Commercial’s Portfolio INZY Stock Details INZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-149,199	Closed	-$597K	–	387
2025 Q2	$597K	Buy	+149,199	New	+$369K	0.05%	266

Crédit Industriel et Commercial's INZY Position: Q3 2025 in Review

Crédit Industriel et Commercial sold out of Inozyme Pharma (INZY) in Q3 2025, closing a stake of 149,199 shares — an estimated $597K sold.

Crédit Industriel et Commercial first reported a position in INZY in Q2 2025 and held it in 1 quarter. The position peaked at $597K in Q2 2025. 0 funds tracked by Wall St. Rank hold INZY as of Q3 2025.

Crédit Industriel et Commercial reported no remaining Inozyme Pharma position as of Q3 2025 after selling out during the quarter.
Crédit Industriel et Commercial sold 149,199 Inozyme Pharma shares in Q3 2025, an estimated $597K.
Crédit Industriel et Commercial first reported a position in Inozyme Pharma in Q2 2025 and held it in 1 quarter.
Crédit Industriel et Commercial's Inozyme Pharma position peaked at $597K in Q2 2025.
0 funds tracked by Wall St. Rank held Inozyme Pharma as of Q3 2025.

Based on Crédit Industriel et Commercial's 13F filing for Q3 2025, filed 7 Nov 2025.